Validation of a model to predict perioperative mortality from lung cancer resection in the elderly

American Journal of Respiratory and Critical Care Medicine

Volumn 179, Issue 5, 2009, Pages 390-395

  Kates, Max ^a   Perez, Xavier ^a   Gribetz, Julie ^a   Swanson, Scott J ^b   McGinn, Thomas ^a   Wisnivesky, Juan P ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Lung malignancy; Lung resection; Risk assessment; Surgical outcomes

Indexed keywords

AGED; ARTICLE; CANCER MORTALITY; CANCER REGISTRY; CANCER SURGERY; COMORBIDITY; CONTROLLED STUDY; FEMALE; HUMAN; LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MALE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; VALIDATION STUDY; AGE; LUNG TUMOR; METHODOLOGY; MORTALITY; PREDICTION AND FORECASTING; REPRODUCIBILITY; SEX DIFFERENCE; STATISTICAL MODEL; UNITED STATES;

AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; PNEUMONECTOMY; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SEX FACTORS; UNITED STATES;

EID: 63349090537     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200808-1342OC     Document Type: Article

References (31)

1. Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ, Mariotto A, Miller BA, Feuer EJ, Altekruse SF, et al., editors. SEER cancer statistics review, 1975-2005 [Internet]. Bethesda, MD: National Cancer Institute; 2007 [accessed 2009 Jan 8]. Available from: http://seer.cancer.gov/ csr/1975-2005/
2. Wingo PA, Cardinez CJ, Landis SH, Greenlee RT, Ries LA, Anderson RN, Thun MJ. Long-term trends in cancer mortality in the United States, 1930-1998. Cancer 2003;97:3133-3275.
3. Strand TE, Rostad H, Moller B, Norstein J. Survival after resection for primary lung cancer: a population based study of 3211 resected patients. Thorax 2006;61:710-715.
4. Mery CM, Pappas AN, Bueno R, Colson YL, Linden P, Sugarbaker DJ, Jaklitsch MT. Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. Chest 2005;128:237-245.
5. Schneider T, Pfannschmidt J, Muley T, Reimer P, Eberhardt R, Herth FJ, Dienemann H, Hoffmann H. A retrospective analysis of short and long-term survival after curative pulmonary resection for lung cancer in elderly patients. Lung Cancer 2008;62:221-227.
6. Janssen-Heijnen ML, Smulders S, Lemmens VE, Smeenk FW, van Geffen HJ, Coebergh JW. Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer. Thorax 2004;59:602-607.
7. Beshay M, Dorn P, Ris HB, Schmid RA. Influence of comorbidity on outcome after pulmonary resection in the elderly. Asian Cardiovasc Thorac Ann 2007;15:297-302.
8. Pennathur A, Abbas G, Christie N, Landreneau R, Luketich JD. Video assisted thoracoscopic surgery and lobectomy, sublobar resection, radiofrequency ablation, and stereotactic radiosurgery: advances and controversies in the management of early stage non-small cell lung cancer. Curr Opin Pulm Med 2007;13:267-270.
9. Heerdt PM, Park BJ. The emerging role of minimally invasive surgical techniques for the treatment of lung malignancy in the elderly. Anesthesiol Clin 2008;26:315-324.
10. Matsuoka H, Okada M, Sakamoto T, Tsubota N. Complications and outcomes after pulmonary resection for cancer in patients 80 to 89 years of age. Eur J Cardiothorac Surg 2005;28:380-383.
11. Strand TE, Rostad H, Damhuis RA, Norstein J. Risk factors for 30-day mortality after resection of lung cancer and prediction of their magnitude. Thorax 2007;62:991-997.
12. Hall BL, Hirbe M, Waterman B, Boslaugh S, Dunagan WC. Comparison of mortality risk adjustment using a clinical data algorithm (American College of Surgeons National Surgical Quality Improvement Program) and an administrative data algorithm (Solucient) at the case level within a single institution. J Am Coll Surg 2007;205:767-777.
13. McGinn TG, Guyatt GH, Wyer PC, Naylor CD, Stiell IG, Richardson WS. Users' guides to the medical literature: XXII. How to use articles about clinical decision rules. Evidence-Based Medicine Working Group. JAMA 2000;284:79-84.
14. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 2002;40:IV-3-IV-18.
15. Cooper GS, Virnig B, Klabunde CN, Schussler N, Freeman J, Warren JL. Use of SEER-Medicare data for measuring cancer surgery. Med Care 2002;40:IV-43-IV-48.
16. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-619.
17. Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol 2000;53:1258-1267.
18. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383.
19. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710-1717.
20. Ravdin PM, Davis G. Prognosis of patients with resected non-small cell lung cancer: impact of clinical and pathologic variables. Lung Cancer 2006;52:207-212.
21. Warren JL, Harlan LC, Fahey A, Virnig BA, Freeman JL, Klabunde CN, Cooper GS, Knopf KB. Utility of the SEER-Medicare data to identify chemotherapy use. Med Care 2002;40:IV-55-IV-61.
22. Virnig BA, Warren JL, Cooper GS, Klabunde CN, Schussler N, Freeman J. Studying radiation therapy using SEER-Medicare-linked data. Med Care 2002;40:IV-49-IV-54.
23. Baldwin LM, Klabunde CN, Green P, Barlow W, Wright G. In search of the perfect comorbidity measure for use with administrative claims data: does it exist? Med Care 2006;44:745-753.
24. Hosmer DW, Hosmer T, Le Cessie S, Lemeshow S. A comparison of goodness-of-fit tests for the logistic regression model. Stat Med 1997;16:965-980.
25. Little AG. Risk and benefit: the eternal yin and yang of thoracic surgery. Thorax 2007;62:929-930.
26. Bleeker SE, Moll HA, Steyerberg EW, Donders AR, Derksen-Lubsen G, Grobbee DE, Moons KG. External validation is necessary in prediction research: a clinical example. J Clin Epidemiol 2003;56:826-832.
27. Reilly BM, Evans AT. Translating clinical research into clinical practice: impact of using prediction rules to make decisions. Ann Intern Med 2006;144:201-209.
28. Little AG, Rusch VW, Bonner JA, Gaspar LE, Green MR, Webb WR, Stewart AK. Patterns of surgical care of lung cancer patients. Ann Thorac Surg 2005;80:2051-2056.
29. Memtsoudis SG, Besculides MC, Zellos L, Patil N, Rogers SO. Trends in lung surgery: United States 1988 to 2002. Chest 2006;130:1462-1470.
30. Dominguez-Ventura A, Allen MS, Cassivi SD, Nichols FC III, Deschamps C, Pairolero PC. Lung cancer in octogenarians: factors affecting morbidity and mortality after pulmonary resection. Ann Thorac Surg 2006;82:1175-1179.
31. Farjah F, Wood DE, Yanez D III, Symons RG, Krishnadasan B, Flum DR. Temporal trends in the management of potentially resectable lung cancer. Ann Thorac Surg 2008;85:1850-1855. (discussion 1856).